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Cloning, bacterial expression, and in vitro purification of ESCRT subunits 
Saccharomyces cerevisiae Vps20, Snf7, Vps24, and Vps2 were cloned into the 
pET23d bacterial expression vector (Novagen) with a homemade N-terminal 
His6-tag, expressed from either BL21 or C41(DE3) E.coli cells, and purified by 
TALON (Clontech) metal bead affinity purification. GST-Vps25 was cloned into 
pGEX6P1 vector and purified on GSH-sepharose beads (GE Healthcare). All 
constructs were verified by DNA sequencing. All expression preps were grown 
initially at 37°C until a cell OD600 of ~0.6-0.8, then induced with IPTG as 
described below. Optimal expression conditions varied for each protein and are 
denoted in Supplemental Table 1. During purification, proteins were reconstituted 
in 500mM NaCl, 20mM HEPES pH7.4, 5mM imidazole buffer. Protein-bound 
TALON beads were washed in 500mM NaCl, 20mM HEPES pH7.4, 20mM 
imidazole, and eluted in 150mM NaCl, 20mM HEPES pH7.4, 400mM imidazole. 
Samples were dialyzed overnight to remove excess imidazole. GST-Vps25 was 
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eluted by addition of 10mM reduced glutathione (Sigma-Aldrich), and underwent 
two-rounds of dialysis to ensure removal of glutathione. Proteins were 
reconstituted into a final buffer of 150mM NaCl, 20mM HEPES pH7.4. All 
reconstituted proteins used in this study were routinely run on SDS-PAGE gels 
and Commassie-stained to access the protein integrity and purity (e.g.: Figures 
S5C and S7G). 
 
Generation of S. cerevisiae Snf7 model using Modeller software 
 
Using the crystal structure of human Vps24 (pdb: 3FRT), a three-dimensional 
model of Saccharomyces cerevisiae Snf7 (resdues 1-183) was generated using 
the comparative protein structure modeling program Modeller (Eswar, Webb et 
al. 2007). The model was visualized using the molecular graphics program 
CCP4mg (McNicholas, Potterton et al. 2011). 
 
Negative stain transmission electron microscopy studies 
 
Samples were incubated for 30 minutes at room temperature, then added 
dropwise to carbon-coated Formvar grids (EMS). Droplets were incubated for 10 
minutes unless specified, then desiccated and negative stained. For negative 
staining, 4% uranyl acetate or 2% ammonium molybdate were added for 30 
seconds, then samples were desiccated and briefly air-dried. For samples using 
Ni2+ NTA-coated 5nm nano-gold beads (Nanoprobes), protein samples were first 
incubated with a 1:25 dilution of nano-gold beads, then added to the 
experimental mixture before being added to TEM grids. For order-of-addition 
experiments, samples were allowed to incubate on grids for 3 minutes, followed 
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by a gentle dehydration by wicking away the liquid and a quick addition of a 
buffer droplet for washing. Subsequent protein was then added for 3 more 
minutes, followed by dehydration and negative staining. Note: being gentle was 
essential, as early attempts to do this sequential addition led to breaks in the 
Formvar® coating. 
For lipid monolayer experiments, monolayers of defined lipid composition 
[20% phophatidylethanolamine (PE), 40% phosphatidylcholine (PC), 30% 
phosphatidylserine (PS),10% phophatidylinositol 3-phosphate (PtdIns(3)P), 
unless otherwise indicated] (Avanti) were generated in a monolayer apparatus by 
dissolving lipids in 95:5 chloroform:methanol and pipetting 1.5µL onto the surface 
of the reaction well containing Buffer A (150mM NaCl, 20mM HEPES pH7.4). 
After 1 hour to allow the evaporation of the chloroform:methanol, monolayers 
spontaneously formed and were adhered to Formvar® carbon-coated TEM grids 
by placing them over the monolayer. Proteins were then added via the injection 
well, and given 20 minutes to assemble on monolayers before negative staining. 
All samples were examined on a FEI Morgnani Transmission Electron 
Microscope at 80-100kV. Digital images were taken using an AMT camera. 
Micrographs are representative of results from multiple independent experimental 
sessions. Image analysis and distance quantitation were conducted using 
ImageJ software (NIH). 
 The table below summarizes the proteins, their concentrations, and 
negative stains used for the TEM micrographs in each Figure. For negative 
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stains, 4% uranyl acetate is denoted as “UA” and 2% ammonium molybdate as 
“AM”. Monolayer is also abbreviated “ML”. 
Fluorescence light microscopy and imaging of yeast 
 
Living yeast were imaged using a DeltaVision RT system (Applied 
Precision), consisting of a Photometrics CoolSNAP HQ Camera, an Olympus 
IX71 Microscope and a DeltaVision RT Standard Filter (FITC for GFP/pHluorin 
samples, and RD-TR-Cy3 for FM-464). Image acquisition, deconvolution, and 
analysis were performed in the program Softworx. 
 
Yeast fractionation and co-immunoprecipitation assays 
 
A total of 15 OD600 of living yeast were, centrifuged, resuspended in 
spheroplasting media containing zymolase to remove the cell wall, washed, and 
ruptured on ice in a pre-chilled cell douncer. Yeast lysate was resuspended in 
1mL of lysis buffer (50mM Tris pH7.4, 10mM EDTA, 200mM sorbitol, and 
protease inhibitor cocktail). For subcellular fractionation assays, lysate was 
centrifuged for 5 minutes at 500xg at 10°C as a general “clearance spin” to pellet 
cell debris. The supernatant was then collected into a fresh ependorf and a 10 
minute 13,000xg P13 spin was done at 10°C. The supernatant (S13) was 
separated from the pellet (P13) fraction and both samples were precipitated in 
10% trichloroacetic acid (TCA). Samples were boiled in sample buffer, run on 
10% SDS-PAGE gels, transferred to PVDF membrane, and Western blotted 
using an in house anti-rabbit Snf7 antibody (Babst, Wendland et al. 1998). 
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Western blots were developed on film using SuperSignal West Pico ECL 
(Thermo Scientific). 
For co-immunoprecipitation assays, 15-25 OD600 of yeast were grown and 
lysed in a douncer as described above. A 1% final concentration Triton X-100 
buffer was added to the supernatant and samples were left on ice for 15 minutes. 
Samples were then given one 13,000xg 10 minute “clearance spin” at 10°C. A 
10% input aliquot was removed. 25µL of EZ View™ anti-FLAG M2 affinity gel 
beads (Sigma Aldrich) was added to the remaining ~900µL of supernatant, and 
samples were incubated for 1 hour at 10°C on a rotator. Samples were then 
sequentially centrifuged and washed 3 times in lysis buffer, then TCA 
precipitated, run on SDS-PAGE gels, and Western blotted. 
 
Snf7redox conformational monitoring assay 
 
Reconstituted Snf7redox was purified and resuspended in Buffer A. Initial 
purifications in Buffer A indicated that Snf7redox existed in mixed oxidized/reduced 
populations, so a low concentration (~500µM) of DTT was added to generate a 
uniformly “open” Snf7redox that could undergo conformational changes. This 
Snf7redox was then incubated at 15µM final concentration with 0.5mg/mL 
liposomes (SUVs) and/or Vps20 and GST-Vps25 for 30 minutes at room 
temperature in 100µL volumes. Experiments which tested the ability of R52E or 
L67E to open Snf7redox were conducted in Buffer A. 
The oxidizing chemical Copper(II) phenathroline (Cu(1,10-
phenathroline)2SO4) (Cu2+Phen) was freshly prepared by separately preparing 
200mM of 1,10-phenanthroline (Phen) in ethanol and 50mM of copper (II) sulfate 
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(CuSO4) in Ionic Buffer (150mM potassium acetate, 5mM magnesium acetate, 
250mM sorbitol, 20mM HEPES pH7.0). Equal volumes of Phen and CuSO4 were 
then mixed creating a brilliant aqua-colored Cu2+Phen solution with a white 
precipitate. To oxidize proteins, 100µL of the Cu2+Phen supernatant was added, 
instantly crosslinking Snf7redox in its current conformational state. Cu2+Phen 
solution undergoes a color change when reduced from a brilliant green to a dark 
brown, so confirmation of the sample’s oxidation is instantaneous.  Samples 
were then TCA precipitated, run on SDS-PAGE gels, and Coomassie stained to 
evaluate the conformation of Snf7redox.  
For experiments conducted in Figure 2C, protein concentrations were-- 
Snf7redox: 15µM in all lanes; Vps20: 75nM (1:200), 750nM (1:20), 3µM (1:5). 
GST-Vps25: 50nM (1:200), 400nM (1:20), 1.5µM (1:5). 
 
Mup1-pHluorin ESCRT cargo sorting assay and flow cytometry 
 
A SNF7::His3, MUP1-pHluorin::kan yeast strain (NBY44) was created by 
mating a SNF7::His3 (MBY24) strain to a MUP1-pHlourin::kan strain (NBY39), 
which was generated using the integrating plasmid pBW1571, a kind gift from 
Beverly Wendlend (Prosser, Whitworth et al. 2010). Wildtype and mutant Snf7 
proteins were expressed ectopically in NBY44 using the pRS416 plasmid 
containing the endogenous Snf7 promoter. For both microscopy and flow 
cytometry analysis, early log cultures were grown to mid-log in the presence of 
methionine to induce the delivery of MUP1-pHluorin to the vacuole. Microscopic 
analysis was performed as described the Experimental Procedures. For flow 
cytometry analysis, mid-log cultures were pelleted and resuspended in PBS for 
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analysis on a BD Bioscience LSRII cytometer. For each sample, ~100,000 cells 
were counted from three cultures originating from three distinct yeast colonies 
and combined for a total analysis of ~300,000 cells. The sorting profiles were 
obtained by overlaying the composite wildtype trace on the composite mutant 
traces. For statistical analysis, each of the three WT samples was subtracted as 
background from each of the individual mutant samples. The cells remaining 
after background subtraction were counted as those eliciting a sorting defect 
distinct from the wildtype population, and were used to calculate the sorting score 
and standard deviation for each composite mutant population. For sample 
comparisons, the wildtype and vector samples were set at 100 and 0, 
respectively, and the mutants were normalized to these values. 
 
GUV-based light microscopy experiments 
GUVs of composition 35%phosphatidylcholine(PC): 
30%phosphatidylserine(PS):25%cholesterol:10%phosphatidylinositol 3-
phosphate(PtdIns(3)P) were made fluorescent by adding 0.05% of the lipophilic 
dye DiI (Invitrogen), and were created by dehydration:rehydration of lipid films on 
glass coverslips. GUVs were resuspended in 150mM NaCl, 20mM HEPES pH7.4 
buffer. To fluorescently label Snf7R52E, we introduced a cysteine at residue 187 
(along a region of the protein unaffected upon manipulation/deletion (Figure 
S4J)), creating Snf7R52E+V187C. We purified this protein from E.coli and covalently 
attached a maleimide-conjugatable Alexa488 fluorophore (Invitrogen) to C187. 
Excess fluorophore was removed by dialysis and the protein was evaluated on 
  172 
SDS-PAGE gels. For experiments, GUVs and protein were mixed in eppendorf 
tubes for 10 minutes, then pipetted onto glass-bottom coverslip dishes (MatTek) 
coated with 1mg/mL BSA to prevent the collapse of GUVs onto the glass. Protein 
concentrations were: Vps20core: 600nM, Snf7R52E-A488: 3µM, Vps24: 1.5µM, 
Vps2: 1.5µM.  
All GUV experiments were conducted using a 100x magnification lens on a 
spinning disc confocal microscopy system (3I Corp) using a DMI 6000B 
microscope (Leica) and digital camera (QuantEM; Photometrics). Images were 
analyzed and processed using Slidebook 5. Movies were compiled from images 






ESCRT‐III “core” domains mediate ESCRT‐III assembly  Previous studies demonstrate that ESCRT‐III subunits are sequentially recruited by ESCRT‐II to the surface of endosomes (Teis, Saksena et al. 2008). ESCRT‐II directly binds Vps20, which promotes the sequential recruitment of Snf7, Vps24, and Vps2 to  form  the  hetero‐tetrameric  ESCRT‐III  complex  (Figure  1A)(Teis,  Saksena  et  al. 2008). All four of these ESCRT‐III subunits are predicted to share a common domain architecture of four alpha helices bundled into an N‐terminal core domain, followed by  an  unstructured  C‐terminal  region  (Figure  1A).  To  better  understand  the molecular  architecture  of  the  ESCRT‐III  complex,  we  first  wanted  to  define architectural  regions  shared  by  its  subunits  that  govern  protein‐protein  and protein‐endosome interactions.   To do this, we generated subunit truncations for each ESCRT‐III subunit and asked if they retained endosomal localization and could interact with other ESCRT subunits. The N‐terminal core domains (which lack their C‐terminal regions and contain only alpha helices1‐4) of Vps20, Snf7, Vps24, and Vps2 were fused to GFP and ectopically expressed in yeast lacking an endogenous copy of each subunit. Like their full‐length counterparts,  the  core  domains  of  all  four  ESCRT‐III  subunits  localize  to  distinct intracellular punctae (Figure 1B‐D and Figure S1A).    We  hypothesized  that  these  punctae  were  class  E  compartments,  aberrant endosome‐derived  structures  generated whenever  the  ESCRT  pathway  is  blocked (Raymond, Howald‐Stevenson  et  al.  1992).  To  confirm  this,  yeast were  co‐labeled 
  175 












A) Representative images localizing GFP-tagged Vps2 and Vps2core (green) to 
endosomal membrane. FM4-64 is red.  
B) Snf7helices1-3 cannot recruit Vps24-GFP (green) to the class E compartment. 
Scale bars: 5µm.   
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Snf7 is activated by displacement of helix5 away from the core  Since all ESCRT‐III N‐terminal core domains are sufficient to localize to endosomal membrane and  recruit other  subunits of  the ESCRT‐III  complex, we  reasoned  that conformational changes displacing the auto‐inhibitory C‐terminus promote ESCRT‐III  assembly  by  exposing  core  contacts.  We  wanted  to  understand  these conformational  changes,  and  chose  to  focus  our  investigation  on  Snf7,  the  most abundant  ESCRT‐III  subunit.  Using  crystal  structures  of  hVps24  (CHMP3),  we generated a three‐dimensional model of Snf7 in its “closed” conformation using the comparative  protein  structure  modeling  program  Modeller  (Eswar,  Webb  et  al. 2006) (Figure 2A). The Snf7 model adopts the same overall fold as hVps24 and has four  discernable  alpha  helices  composing  its  core  domain  with  a  helix5  forming intramolecular contacts with the core.   We hypothesized  that Snf7 activation  involves  the conformational displacement of helix5  away  from  its  core  contacts,  allowing  the  core  domain  to  be  accessible  for potential  protein  and  membrane  interactions.  To  investigate  this  conformational change,  we  developed  a  cysteine‐based  cross‐linking  assay  that  directly monitors the conformational  state of Snf7. We  first  selected residues on both helix5  (T179) and  the  core  region  closely  juxtaposed  to  helix5  (A51)  (Figure  S2A).  Taking advantage  of  the  fact  that  endogenous  Snf7  contains  no  cysteines,  we  converted these  residues  to  cysteines  and purified  Snf7T179C,  Snf7A51C,  and  the dicysteine mutant (Snf7redox) from E.coli.  
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In the presence of the reducing agent dithiothreitol (DTT), all Snf7 cysteine mutants migrated to ~37kDa on SDS‐PAGE gels, consistent with cysteineless Snf7 (Figure 2B and Figure S2B). We next oxidized the cysteine‐containing Snf7 mutants by adding the  chemical  oxidant  copper(II)  1,10‐phenathroline  (Cu2+Phen),  and  ran  these samples  on  non‐reducing  SDS‐PAGE  gels.  Strikingly,  Snf7redox  underwent  a migration  shift  from ~37kDa  to ~30kDa  in  the presence  of  Cu2+Phen,  suggesting intramolecular disulfide bond formation (Figure 2B). Snf7A51C and Snf7T179C did not shift their migrations upon oxidization. The Snf7redox migration shift indicates the di‐sulfide cross‐linking of Snf7redox into an inactive “closed” conformation.   Since  the  Snf7redox migration  shift  may  be  correlated  to  its  “open”  and  “closed” conformational states, we next asked if ESCRT subunits that initiate Snf7 activation promote Snf7redox  “opening”.  Snf7  is activated by Vps20, which  is  itself  activated by the ESCRT‐II subunit Vps25 (Saksena, Wahlman et al. 2009). Thus, Vps25, Vps20, and  liposomes  were  incubated  with  Snf7redox  in  mildly  reducing  conditions  to allow  conformational  changes within  Snf7redox.  The  samples were  then  oxidized with Cu2+Phen and run on non‐reducing SDS‐PAGE gels.   The  separate  incubation  of  Snf7  with  either  large  unilamellar  vesicles  (LUVs, ~1micron)  or  small  unilamellar  vesicles  (SUVs,  <1  micron)  failed  to  “open” Snf7redox  (Figure  2C).  Similarly,  experiments  adding  SUVs  together  with  either Vps20 or Vps25 separately, or adding Vps25 and Vps20 together but without SUVs, all failed to “open” Snf7redox (Figure S2C). However, the complete addition of SUVs, 
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Vps25, and Vps20 caused a dramatic shift of Snf7redox from its “closed” to “open” conformational  state  (Figure 2C). This  effect was dose dependent, with  increasing concentrations  of  Vps20  and  Vps25  inducing  more  Snf7redox  to  an  “open” conformation.  This  indicates  that  Vps25  and  Vps20  promote  the  conformational “opening”  of  Snf7  on  membrane  by  displacement  of  helix5  away  from  the  core domain.     
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Figure  2‐  Snf7  is  activated  by  displacement  of  helix5  from  intra‐molecular 








A) Surface model of Snf7 helix5-core contacts with residues-of-interest labeled. 
Below the main image are two models in ribbon (left) and electrostatic surface 
(right) formats of modeled Snf7. The linker-core contacts mutated in Snf7K-linker 
are circled (blue: + charge, red: -charge).  
B) DTT-treated Snf7redox and Snf7 containing no cysteines at 75µmol, 225µmol, 
and 375µmol amounts.  
C) Control Snf7redox experiments on non-reducing gels. Snf7redox is primarily 
“closed” when incubated separately with only membranes (SUVs), 
membranes+Vps20, membranes+Vps25, or Vps20 and Vps25 without 
membrane. The addition of all three components promotes “opening”. All 
samples contain Cu2+Phen.  
D) Snf7 orthologues from budding yeast (Sc), Candida albicans (Ca), mouse 
CHMP4B (Mm), human CHMP4B (Hs), and C. elegans (Ce). Predicted alpha-
helices are boxed above the alignment. Residues of interest are purple.  
E) Snf7R52E+redox and Snf7L67E+redox proteins are more “open” in solution without 
the addition of membranes or activating proteins (non-reducing gel). Standard 
deviations given.   
F) Liposome flotation assays of Snf7L67E and Snf7K-linker. B=bound, U=unbound. 
Standard deviations given.    
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Structure‐based mutations promote Snf7 “opening”  Since  Snf7  activation  involves  helix5  displacement,  we  reasoned  that  mutations disrupting  helix5‐core  contacts  would  promote  Snf7  activation,  and  consequently drive Snf7 to endosomes. Using site‐directed mutagenesis, we substituted residues R52 and L67 on the Snf7 core domain with glutamates, which would disrupt helix5‐core contacts, but not add additional positive‐charge to Snf7 that may inadvertently promote membrane binding (Figure S2A&D). To test if these substitutions promoted Snf7 activation, we first examined the endosomal localization of the mutant proteins by  sub‐cellular  fractionation.  Normally,  ~65%  of  Snf7  molecules  localize  to  the cytoplasmic  supernatant  fraction  (S13)  after  a 13,000x  centrifugation  spin  (Babst, Katzmann  et  al.  2002).  The  remaining  ~35%  resides  in  the  membrane‐enriched pellet fraction (P13). Snf7R52E and Snf7L67E displayed enhanced P13 fractionation (~55% for Snf7R52E and ~46% for Snf7L67E, respectively) (Figure 2D), consistent with enhanced Snf7 activation.  We hypothesized  that  the R52E and L67E substitutions would promote Snf7redox “opening” independent of the presence of active Vps20 and membranes. To test this, we  introduced  the  R52E  and  L67E  mutations  into  Snf7redox  constructs  and oxidized  the  purified  proteins  with  Cu2+Phen.  As  predicted,  the  R52E  and  L67E substitutions  enhanced  the  percentage  of  Snf7redox  remaining  in  an  “open”  state after  their  oxidation  by  Cu2+Phen  (R52E: ~40%  open,  L67E: ~38%  open,  versus redox  alone:  ~28%  open)  (Figure  S2E).  This  suggests  that  these  mutations  are 
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disrupting  the  Snf7  closed  conformation  by  increasing  the  physical  separation between the core and helix5.   We next attempted to “open” Snf7 by mutating residues on or near helix5 that make contact  with  the  core  domain.  While  helix5  primarily  interacts  with  the  core  via weak hydrophobic contacts, we noticed a highly conserved acidic patch in the linker region  immediately  preceding  helix5.  This  patch  contains  the  sequence  motif EDEL(D/M)EE and is almost completely conserved between yeast and man (Figure S2D).  Several  negatively‐charged  residues  within  this  motif  form  electrostatic contacts  with  positively‐charged  residues  along  the  core  domain  (Figure  S2A). Inversion of these negatively‐charged residues to positively‐charged lysines (Snf7K‐linker)  significantly  enhanced Snf7 P13  fractionation  (66% P13),  suggesting  these mutations  may  drive  Snf7  “opening”  by  displacing  the  linker  and  helix5  from contacting  the  core  (Figure  2D).  Snf7K‐linker  also  changed  its  migration  pattern, likely due to a net change in protein charge on SDS‐PAGE gels.  Since our Snf7 mutants displayed enhanced P13 localization, we wanted to directly assay their ability to interact with lipid membranes. To do this, we next performed liposomes  flotation  experiments  with  purified  Snf7  mutants  to  confirm  they interacted with membranes better  than  “closed” wildtype  Snf7. Whereas wildtype Snf7 displayed very low liposome binding (~6%), Snf7R52E, Snf7L67E, and Snf7K‐linker  showed  enhanced  liposome  binding  (27%,  38%,  and  32%,  respectively) 
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(Figure 2E and Figure  S2F). As  a positive  control,  the  Snf7core domain  alone was purified and displayed the most robust membrane binding (~56%).   Taken  together  these observations  indicate  that Snf7 exists  in an  inactive  “closed” conformation  that  involves  intramolecular  contacts  between  the  core  domain  and the  linker‐helix5 region. We propose that when Vps20 is activated,  it recruits Snf7 and induces conformational changes within Snf7 that promote the movement of the linker  and  helix5  away  from  the  core.  This  exposes  regions  of  the  core  that were buried, allowing them to interact with the endosome and other ESCRT‐III subunits. Several  highly‐conserved  lysines  line  the  core  domain  and  form  electrostatic contacts with the linker (Figure S2A). Once exposed by conformational opening they could potentially mediate Snf7 membrane binding (unpublished observations).     
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Activated Snf7 assembles into protofilaments Once activated, Snf7 homo‐oligomerizes forming the most abundant portion of the ESCRT‐III complex (Teis, Saksena et al. 2008). Since Snf7R52E appeared to be auto‐activated,  we  hypothesized  that  it  would  readily  form  higher‐order  structures visible  by  negative  stain  transmission  electron  microscopy  (TEM).  Whereas wildtype Snf7 does not assemble into ordered structures (Figure 3A), we observed the robust assembly of Snf7R52E into long protofilaments 14.5±3.7nm in diameter (Figure 3B&C).  Protofilament abundance and length were dependent on the period of time samples incubated on TEM grids prior to negative staining, suggesting the Formvar grid was the  site  of  protofilament  formation  (Figure  S3A&C).  Protofilament  formation was also  protein  concentration  dependent,  with  robust  formation  at  34.5µM,  reduced protofilament  formation  at  12.5µM,  and  no  visible  protofilaments  under  5µM concentration  (Figure  S3B).  The  protofilaments  were  often  “capped”  by  rings  or spirals at one or both ends (Figure 3B‐F, and red arrows). Longer incubation times led  to  more  abundant  ring/spiral  “caps”  on  protofilaments  (see  Figure  S3D  for quantification).  To further examine the molecular architecture of Snf7 protofilaments, we used 2% ammonium  molybdate  as  a  negative  stain.  Ammonium  molybdate  forms  a  fine microcrystalline coat on biological samples, preserving their ultrastructural detail at the cost of electron density. It had the general affect of sharpening the resolution of 
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A) Snf7R52E protofilament assembly across increasing grid incubation times.  
B) Snf7R52E protofilament formation is protein concentration dependent.  
C) Quantification of Snf7R52E protofilament length as a function of incubation time 
on TEM grids. All protein was added at 34.5µM.  
D) Quantification of the number of rings formed along the length of Snf7R52E 
protofilaments formed over different time periods. The number of rings decorating 
the protofilaments increases as incubation time increases.  
E) TEM micrograph of Snf7core mixed with Snf7R52E (1:1).  
F) Quantification of the length of Snf7R52E protofilaments formed from Snf7R52E 
alone or Snf7R52E:Snf7core (1:1) (9min incubation). Scale bar: Panels A&B-500nm, 
Panel E-100nm.   
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The Snf7 C‐terminal region stabilizes protofilaments Since  the  diameter  of  Snf7  sub‐filaments  suggested  they  were  composed  of  Snf7 monomers packed head‐to‐tail  into  a  chain, we hypothesized  that  Snf7core would be  sufficient  to  form  protofilaments  in  vitro.  Surprisingly,  Snf7core  failed  to assemble  into  protofilaments  (Figure  4A&B).  Consistent with  this, when  Snf7core and Snf7R52E were mixed at 1:1 stoichiometric ratios, protofilaments were formed, but  their  lengths  were  reduced  dramatically  (Figure  S3E&F).  This  suggested  that Snf7R52E  was  able  to  interact  with  Snf7core,  but  Snf7core  negatively  affected protofilament elongation.   Since  Snf7core  appeared  unable  to  polymerize,  we  hypothesized  that  the  Snf7  C‐terminal  region  may  play  a  role  in  Snf7  homo‐oligomerization.  To  test  this,  we generated several mutants which perturb the C‐terminal region and evaluated these mutations with three different assays to test: 1) if the mutants could assemble into protofilaments  in vitro, 2)  if  they  retained  the ability  to  interact with endogenous Snf7  in  vivo  by  co‐immunoprecipitation,  and  3)  if  the  mutants  were  able  to complement ESCRT pathway function when expressed in snf7Δ yeast.  We  first  investigated  if  helix5  was  involved  in  Snf7  oligomerization.  We  deleted helix5  (residues  170‐183)  on  the  R52E  background  and  found  that  purified Snf7R52E+Δhelix5  failed  to  form  protofilaments  (Figure  4D).  To  test  if  mutating helix5 affected Snf7 oligomerization in vivo, we next expressed Snf7Δhelix5 in yeast with  a  chromosomally  integrated  SNF7‐3xFLAG  gene  and  performed  anti‐FLAG 
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A) Representative images of yeast expressing Mup1-GFP (green) +/- 
methionine. FM4-64 is red. 5µm scale bar.  
B) Table summarizing several sorting profiles from Panel C.  
C) Flow cytometry sorting profiles of FITC-excited yeast expressing vector or 
Snf7 mutants and Mup1-pHluorin. Profiles represent an average of three 
independent experiments and ~300,000 yeast. y-axis: cell number, x-axis: 
fluorescence.  
D-K) Representative images of snf7Δ yeast co-expressing different Snf7 mutants 
and GFP-Cps1 (green). Scale bars: 5µm. 
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A pH‐sensitive ESCRT cargo quantitatively scores Snf7 function Previous  studies  have  suggested  that  Snf7  homo‐oligomerization  promotes  ILV formation, and thus the delivery of cargoes to the vacuole lumen (Teis, Saksena et al. 2008;  Teis,  Saksena  et  al.  2010).  Since we  characterized mutations  that  impaired Snf7  oligomerization,  we  next  developed  an  assay  to  quantitatively  access  their effects  of  ESCRT  pathway  function.  This  assay  utilizes  a  pH‐sensitive  GFP  variant (pHluorin)  fused to  the plasma membrane methionine transporter Mup1 (Prosser, Whitworth et al. 2010) (see Figure 4K for conceptual model).   When  extracellular  methionine  levels  are  low,  Mup1‐pHluorin  localizes  to  the plasma membrane and fluoresces brightly when excited (Figure 4G). In response to increased  extracellular methionine, Mup1  is  rapidly  endocytosed  and delivered  to the vacuole lumen in an ESCRT‐dependent manner (Figure S4A) (Lin, MacGurn et al. 2008). At  the vacuole, pHluorin  fluorescence  is quenched due  to  the acidity of  the vacuole  lumen  (Figure  4H).  Since  ESCRT  dysfunction  results  in  a  failure  to  sort Mup1‐pHluorin into ILVs, we predicted that cells with a defective ESCRT‐III would display  persistent  pHluorin  fluorescence  in  the  presence  of  methionine  (Figure 4I&J).  In  this way,  pHluorin  fluorescence  intensity  is  a quantifiable  readout of  the efficiency of ESCRT‐III‐mediated ILV formation.   To  quantitatively  score mutations  that  affect  Snf7  oligomerization,  we  ectopically expressed  Snf7  mutants  in  Mup1‐pHluorin‐expressing  yeast  lacking  endogenous Snf7, and induced Mup1‐pHluorin endocytic uptake by adding methionine. We then 
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used  flow  cytometry  to  quantify  the  pHluorin  fluorescence  intensities  of  at  least 300,000  yeast  expressing  each mutant. When  the  fluorescence  distribution  of  the population  was  plotted,  each  Snf7  mutant  exhibited  a  unique  and  highly reproducible sorting profile (Figure S4C). We then calculated the percent deviation of each mutant from the wildtype profile to assign a “score” that reflects the severity of each mutation on ESCRT pathway  function. The Table  in Figure 4L summarizes these calculations.   Notably, ~79% of yeast expressing Snf7R52E sort Mup1‐pHluorin as efficiently as wildtype  cells,  resulting  in  a  sharply‐peaked  sorting  profile  that  is  only  slightly brighter  when  compared  to  wildtype  yeast  (Figure  S4C).  This  indicates  that Snf7R52E  retains  functionality  in  vivo.  Although  the  precise  reason  for  the  slight fluorescence  shift  is  unclear,  it  may  be  attributed  to  perturbing  the assembly:disassembly  equilibrium  of  ESCRT‐III,  which  may  affect  ILV  formation. Consistent with this, mutations localized within the helix5‐core contact site elicited Mup1‐pHluorin  sorting  defects  (L67E  and  A51E),  whereas mutations  outside  this region had almost no effect on sorting (K60E and K79E) (Figure S4B&C).  Consistent with the need for helix5 to efficiently oligomerize  in vitro, Snf7Δhelix5‐expressing yeast displayed a significant Mup1‐pHluorin sorting defect,  resulting  in only  ~32%  the  sorting  efficiency  of  wildtype  cells  (Figure  4L).  Snf7Δlinker‐expressing  yeast  also  failed  to  efficiently  sort Mup1‐pHluorin,  functioning  at  only ~9%  of  wildtype  levels.  This  was  similar  to  Snf7core  alone,  which  had  a  sorting 
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phenotype  similar  to  snf7Δ  yeast.  Surprisingly,  Snf7K‐linker  also  failed  to  sort Mup1‐pHluorin efficiently  (~7% sorting efficiency). The reason  for  this  is unclear, but  may  be  due  to  the  inherent  instability  of  the  short  (~100nm)  filaments  this mutant formed (Figure 4F).  To confirm that the sorting of Mup1 represents a general readout of ESCRT pathway function, we examined the sorting of another ESCRT‐dependent cargo: the vacuolar protease  Cps1.  Snf7  mutants  were  co‐expressed  in  yeast  expressing  GFP‐Cps1, which is sorted from the Golgi to the vacuole in an ESCRT‐dependent manner. The qualitatively scored ability of mutants to sort GFP‐Cps1 closely matched the sorting profiles  of  Mup1‐pHluorin  (Figure  S4D‐K),  suggesting  that  the  Mup1‐pHluorin sorting profile represent the general sorting capability of the ESCRT pathway.   Altogether, these data underscore the involvement of the Snf7 C‐terminal region in stabilizing  Snf7  homo‐oligomers.  It  suggests  that  this  region,  following  subunit “opening”,  may  form  contacts  with  a  neighboring  Snf7  monomer  to  promote oligomerization. Furthermore, the use of Mup1‐pHluorin as a pH‐sensitive cargo has allowed us for the first time, to our knowledge, to quantitatively access the effect of individual point mutations within the ESCRT pathway.     
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Figure  5‐  Snf7  assembles  into  spirals  on  lipid monolayers  and  co‐assembles 







A) Measured diameters of Snf7R52E spirals.  
B) Comparative micrographs of lipid monolayers of two different lipid 
compositions. Monolayers of high lipid acidity (left column) promote Snf7R52E 
spiral assembly. Monolayers with lowered lipid acidity (right column) attenuate 
spiral formation. The monolayer edge is labeled in each micrograph.  
C) Coomassie-stained gel of Snf7R52E, Vps24, and Vps2. D-F) TEM micrographs 
of Snf7, Vps24, and Vps2 co-assembly reactions omitting Vps2 (D), Vps24 (E) or 
Snf7R52E (F).  
G) Quantification of the length of protofilaments formed from either Snf7R52E 
alone or the co-assembly of Snf7R52E, Vps24, and Vps2 (3min incubation).  
H) Order-of-addition experiments showing Vps24 and Vps2 can induce helical 
architecture from pre-assembled Snf7 protofilaments. Protein was allowed to 
assemble on TEM grids for 3 minutes, followed by brief dehydration, a buffer 
wash step, and addition of the next protein. The table summarizes the efficiency 
of helix formation on a scale of four “+” marks. I) Speculative model of ESCRT-III 
helices on rigid supported monolayers versus a bendable endosome. Scale bars: 
Panels B&H- 100nm, Panels D-F- 500nm.   
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Snf7, Vps24, and Vps2 co‐assemble into protein helices Spirals  are  geometrically  two‐dimensional  structures.  In  agreement with  this,  the Snf7 spirals we observed appeared “flat” and thus ostensibly incapable of mediating the drastic  three‐dimensional membrane  remodeling necessary  for  ILV  formation. Since  Snf7  oligomerization  recruits  ESCRT‐III  subunits  Vps24  and  Vps2  to endosomes,  we  hypothesized  that  these  proteins  may  modulate  the  molecular architecture  of  Snf7  polymers  (Babst,  Katzmann  et  al.  2002;  Teis,  Saksena  et  al. 2008).  To  test  this,  we  reconstituted  full  length  Vps24  and  Vps2  from  E.coli  and incubated  them  with  Snf7R52E  at  cellular  abundance  levels  (~2:1:1  ratios; Snf7:Vps24:Vps2) (Figure S5C).  We  first  examined  these  co‐assembly  experiments  on  TEM  grids.  As  before, Snf7R52E alone polymerized  into  long protofilaments capped with a ring or spiral (Figure  5D).  Strikingly,  the  simultaneous  addition  of  Snf7R52E,  Vps24,  and  Vps2 generated  coiled  helices  (a  geometrically  three‐dimensional  spiral)  that  extended across the grid surface (Figure 5E&F). The filaments composing these helices were identical in diameter to Snf7R52E protofilaments (~9nm), but generally shorter and of variable length (mean length: 290±185nm) (Figure S5G). These helical polymers are  likely  hetero‐oligomers  containing  Snf7R52E,  Vps24,  and  Vps2  because experiments including only two of the three subunits at 1:1 ratios did not produce helices  (Figure  S5D&E).  Similarly,  co‐incubated  Vps24  and  Vps2  (1:1)  failed  to oligomerize,  likely  because  there  was  no  Snf7  present  to  induce  Vps24/Vps2 activation (Figure S5F).  
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 We next added Snf7R52E, Vps24, and Vps2 to lipid monolayers. The proteins again assembled into helices similar to those formed on TEM grids. High magnification of these  helices  indicated  that  they  appeared  to  retain  a  three‐dimensional  coiling architecture  indicative  of  protein  helices  like  those  formed  by  the  membrane scission machine  dynamin  (Carr  and  Hinshaw  1997)  (Figure  5G‐I).  These  helices projected  across  the  monolayer  surface  and  were  very  distinct  from  the  spirals Snf7R52E  formed  on  its  own.  They  displayed  an  average  outer  diameter  of 85.4±6.5nm.  Several  were  closely  associated  with  liposomes  that  spontaneously form  as  a  biproduct  of  monolayer  biogenesis,  suggesting  the  helices  can  readily interact with lipid membranes (Figure 5G‐I).    Since Vps24 and Vps2 are recruited to endosomes after Snf7, we next asked if these proteins could remodel pre‐existing Snf7 protofilaments into helices. To do this, we assembled  Snf7  into  protofilaments  on  TEM  grids,  washed  unassembled  protein away by droplet exchange, and added buffer containing Vps24 and Vps2 to the grids. We  then  examined  the  grids  and  qualitatively  scored  for  the  efficiency  of  helix formation relative to a control grid containing co‐incubated Snf7:Vps24:Vps2. When Vps24 and Vps2 were added to pre‐assembled Snf7 protofilaments, they were able to  efficiently  induce  helix  formation  (Figure  SH  i&ii).  Similarly,  we  also  observed slightly less efficient helix formation when Snf7R52E and Vps24 were first added to grids, followed by a wash and Vps2 (Figure SH iii). In contrast, sequential addition of Snf7R52E, Vps24, and Vps2 in three stages, or the addition of Vps24 and Vps2 first, 
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followed by Snf7R52E led to drastically reduced helix formation (Figure SH iv & v). These  experiments  imply  that  Vps24  and  Vps2  could  potentially  remodel  pre‐existing  Snf7  polymers  into  helices  during  the  ordered  assembly  of  ESCRT‐III (Figure 5J).  
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Vps24  and  Vps2  promote  ESCRT‐III  associated  membrane  invaginations  on 
GUVs Although TEM imaging of lipid monolayers provides high‐resolution visualization of ESCRT‐III  assembly,  the monolayers  are  adhered  to  a  rigid  grid  support  and  thus cannot  be  deformed  by  ESCRT‐III  (Figure  S5I).  Since  Snf7,  Vps24,  and  Vps2  co‐assembled into helices with implied membrane sculpting potential, we next wanted to  investigate  if  these  proteins  could  drive  or  be  associated  with  membrane invaginations. To do this, we generated GUVs labeled with the lipophilic dye DiI. We noted  that  some  GUVs  could  spontaneously  deform  in  solution,  so  we  wanted  to ensure  we  could  distinguish  membrane  invaginations  that  were  specifically associated  with  ESCRT‐III  proteins.  We  fluorescently  tagged  Snf7R52E  by engineering a cysteine into its C‐terminus (V187C), to which we covalently attached a maleimide‐conjugatable Alexa488 fluorophore (Figure S6A). Although Snf7R52E‐A488 was able  to  interact with GUVs  (Figure S6B), we wanted  to  reconstitute  full ESCRT‐III assembly, and so purified Vps20core, which was sufficient to recruit Snf7 to endosomal membranes (Figure 1E). GUVs treated with Vps20core and Snf7R52E‐A488  displayed  punctal  Snf7R52E‐A488  labeling  across  their  surfaces,  but  were notably devoid of ESCRT‐III‐associated invaginations (Figure S6C&I).   In striking contrast, the addition of all four ESCRT‐III subunits (now including Vps24 and  Vps2)  led  to  the  formation  of  distinct  membrane  invaginations  with  which Snf7R52E‐A488  punctae  associated  (Figure  S6D‐G).  Snf7R52E  punctae  stably associated  with  these  invaginations  over  time  and  several  invaginations  were 
  215 
observed  to  form  underneath  sites  of  Snf7R52E  enrichment,  suggesting  they may form  as  a  consequence  of  ESCRT‐III  assembly  (Figure  S6H  and  SMovie  1). Interestingly,  Snf7R52E–A488  remained  at  the  top,  neck  region  of  these invaginations and was mostly excluded  from the bud  that protruded  into  the GUV interior. This may indicate that ESCRT‐III assemblies containing Snf7R52E may have affinity for regions of high membrane curvature located at the necks of membrane invaginations.  Together  with  our  TEM‐based  observations,  we  propose  that  Vps24  and  Vps2 induce  structural  rearrangements  in  Snf7  polymers  that  create  helices  with potential membrane sculpting properties (Figure 5J). We speculate that because of the rigidity of TEM grid support, these helices cannot deform the lipid monolayer on which they assemble. Instead, they stably associate with the monolayer surface and extend across it (Figure S5I).  
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A) Coomassie-stained and UV-excited gels of unlabelled Snf7R52E+V187C and 
Snf7R52E+V187C with covalently attached Alexa488 fluorophore (referred to as 
Snf7R52E-A488).  
B) Fluorescent DiI-labeled GUV displaying associated Snf7R52E-A488 protein on 
its surface. Separate Alexa488 and DiI-channel images are shown below the 
merged panel.  
C) Fluorescent GUV incubated with Vps20core and Snf7R52E–A488 (1:5 ratio). A 
Snf7R52E-A488 punctae on the GUV surface is marked with an arrow.  
D-G) Different fluorescent GUVs incubated with Vps20core, Snf7R52E–A488, 
Vps24, and Vps2 at a 2:10:5:5 ratio. Numerous Snf7R52E-A488 punctae are 
present on the surface of these GUVs, and are associated with invaginations. H) 
Time-lapse frames of a membrane invagination forming that is associated with 






A-C) TEM micrographs of ESCRT-II, Vps20, Snf7 co-assembly reactions 
containing all three components (A) or omitting Vps20 (B) or ESCRT-II (C).  
D) Micrographs of ESCRT-II:Vps20:Snf7R52E rings on TEM grids (left) or lipid 
monolayers (right).  
E) ESCRT-II:Vps20:Snf7R52E:Vps24:Vps2 (1:2:10:5:5) rings on TEM grids.  
F) Measured ring diameters from Panel E.  
G) Coomassie-stained gels of Snf7 mutant proteins used in this study. 
Coomassie-stained gels of ESCRT-II, Vps20, and Snf7R52E used in the ESCRT-
II:ESCRT-III co-assembly reactions. Scale bars: Panels A-C-500nm, Panels 
D&E-100nm.   
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We hypothesized that the globular densities associated with these rings represented ESCRT‐II  complexes  that  were  potentially  modulating  ESCRT‐III  ring  formation. When  ESCRT‐II  was  examined  by  TEM,  globular  protein  densities  14.6±2.9nm  in diameter were observed that appeared very similar to the densities associated with ESCRT‐III  rings  (Figure  6D).  Crystallographic  studies  suggest  this  diameter  is consistent with the predicted size of negatively stained ESCRT‐II complexes (Hierro, Sun et al. 2004). To confirm that these densities were indeed ESCRT‐II, the complex was  pre‐incubated  with  5nm  Ni2+NTA‐coated  nano‐gold  beads,  which  can  bind His6‐tags with high affinity. Single 5nm nano‐gold beads now decorated the protein densities, confirming they were ESCRT‐II (Figure 6D).   We  next  added  Vps20  and  Snf7R52E  with  an  ESCRT‐II  sample  that  was  pre‐incubated with 5nm nano‐gold beads. We observed protein rings dotted by a single nano‐gold  labeled ESCRT‐II  (Figure 6E). These observations  suggest  that ESCRT‐II and Vps20 may coordinate the polymerization of Snf7 polymers into highly curved ESCRT‐II:ESCRT‐III super‐complexes (Figure 6F).   Interestingly,  when  ESCRT‐II,  Vps20,  Snf7R52E,  Vps24  and  Vps2  were  all  co‐incubated  at  a  1:2:10:5:5  ratio,  almost  no  helical  protofilaments  were  observed. Instead, we observed primarily rings with diameters 70.2±18.6nm similar to those formed by only ESCRT‐II, Vps20, and Snf7R52E (Figure S7D‐F).  
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Altogether,  these  data  suggest  that  ESCRT‐II  and  Vps20  may  coordinate  the architecture of Snf7 polymerization,  favoring  the  formation of highly curved rings. These rings provide a possible structural explanation for the physical sequestration of transmembrane cargoes at distinct regions of the endosome surface prior to their packaging into vesicles.  
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Discussion The  ESCRT  pathway  mediates  the  capture,  sequestration,  and  sorting  of transmembrane proteins into multivesicular bodies that are ultimately delivered to the vacuole  for degradation. The sequential assembly of distinct ESCRT complexes suggests an exquisite division of labor to achieve cargo sorting. Whereas ESCRTs‐0,‐I, and –II form stable hetero‐oligomeric complexes, the dynamic cycling of ESCRT‐III subunits  from  inactive  monomers  into  active  polymers  drives  the  formation  of cargo‐laden  vesicles.  Here,  we  have  reconstituted  distinct  stages  of  this  dynamic ESCRT‐III assembly that provide structural insights for how ESCRT‐III achieves both cargo capture and vesicle formation.   Based  on  this  work  and  the  collective  work  of  the  ESCRT  field,  we  propose  a comprehensive model  for ESCRT‐mediated MVB biogenesis: 1) ESCRT‐0,‐I,  and –II engage ubiquitinated cargo and concentrate this cargo into a patch on the endosome surface,  2)  ESCRT‐II  initiates  the  assembly  of  an  ESCRT‐III  ring‐like  polymer  by directly binding Vps20, 3) ESCRT‐III assembles by the sequential recruitment of its subunits, ultimately forming a helix, 4) the AAA ATPase Vps4 is recruited by ESCRT‐III to recycle the ESCRT machinery off the MVB.  In  our  present  work,  we  engineered  precise  residue  substitutions  that  drive  the robust  oligomerization of  Snf7. We  then used  a  combination of TEM, biochemical, and  cell  biological  techniques  to  elucidate  the  mechanism  for  Snf7  oligomeric assembly.  Reconstituting  Snf7  activation  allowed  us  to  characterize  distinct  sub‐
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reactions  that  occur  during  the  ordered  assembly  of  ESCRT‐III.  Ultimately,  we propose  that  ESCRT‐II  and  ESCRT‐III  co‐assemble  into  cargo‐capturing  ring complexes  that  are  transformed  into  membrane  sculpting  helices  to  drive  ILV formation.  When assembled on  an  endosome,  a ~65nm diameter protein  ring would  enclose approximately  3320nm2  of  membrane  surface.  If  this  membrane  area  were remodeled into a sphere it would form a vesicle ~32nm in diameter, consistent with the  observed  size  of  ILVs  in  yeast  MVBs  (Wemmer,  Azmi  et  al.  2011).  Thus,  we propose that an ESCRT‐II:ESCRT‐III ring super‐complex assembles on the endosome surface and simultaneously mediates: 1) physical sequestration of  transmembrane cargoes  that will  be  packaged  into  the  ILV,  and  2)  demarcation  of  the membrane surface area that is sculpted into the cargo‐laden ILV (Figure 7A&B). Following Snf7 homo‐oligomerization,  Vps24  and Vps2  are  recruited  to  the  assembling  ESCRT‐III complex,  potentially  promoting  the  formation  of  an  ESCRT‐III  helix  with  vesicle sculpting properties (Figure 7C&D).  Recent studies using giant unilamellar vesicles (GUVs) demonstrated that ESCRT‐III constitutes  the  minimal  machinery  necessary  to  achieve  ILV  formation  in  vitro (Wollert  and Hurley 2010). While  these  studies  indeed highlighted  the  abilities of ESCRT‐III to bind to and deform membranes, they were limited by the resolution of fluorescence  microscopy  and  therefore  provided  little  information  as  to  the architecture  ESCRT‐III  adopts  during  vesicle  budding.  Here,  we  have  investigated 
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the  underlying  molecular  mechanism  of  ESCRT‐III‐mediated  membrane  sculpting using the high visual resolution provided by TEM. Surprisingly, we find that specific ESCRT subunits modulate distinct architectural stages of ESCRT‐III assembly. This is consistent  with  the  fact  that  all  core  ESCRT  proteins  are  essential  to  MVB  cargo sorting; the loss of any subunit blocks cargo delivery to the vacuole.   
ESCRT‐II and Vps20 mediate Snf7 ring formation for cargo capture ESCRT‐II  and  Vps20,  which  physically  links  ESCRT‐II  to  Snf7,  appear  to  regulate both the size and shape of Snf7 oligomers. As such, ESCRT‐II and Vps20 promote the formation  of  rings ~65nm  in  diameter  that  are  ideal  for  physically  capturing  and sequestering  ubiquitinated  cargoes  at  the  endosome.  Since  ESCRT‐II  contains  two Vps25  subunits  that  each  interact  with  a  Vps20,  a  two‐armed  ESCRT‐II  may coordinate  the  formation  of  ESCRT‐III  rings  by  interacting  with  both  Snf7  sub‐filaments simultaneously. This  is consistent with previous studies indicating that a two‐armed ESCRT‐II was necessary for ILV formation in yeast (Teis, Saksena et al. 2010).   Although  ESCRT‐II  promotes  the  formation  of  highly  curved  ESCRT‐III  rings,  it  is notable that Snf7 protofilaments naturally spiral on lipid membranes. This intrinsic curvature  is  likely  determined  on  the  molecular  level  by  specific  interactions between Snf7 monomers that set the curvature pitch of the polymer. The flexibility of  the Snf7  linker region, which has been shown in other ESCRT‐III subunits  to be 
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associated  with  conformational  changes,  may  also  provide  flexibility  that  allows protofilament bending (Lata, Roessle et al. 2008).   Other protein polymers have been shown to undergo drastic changes in shape due to  conformational  changes  within  their  monomers.  FtsZ,  a  bacterial  cytoskeletal protein, assembles into straight homo‐oligomeric protofilaments that are converted into spirals and rings by conformational changes within their monomers (Lu, Reedy et  al.  2000).  Furthermore,  these  architectural  dynamics  can  generate  mechanical force that bends lipid membranes (Osawa, Anderson et al. 2009). FtsZ and ESCRT‐III have  both  been  proposed  to  play  direct  roles  in  the  membrane  remodeling necessary for cytokinesis, implying that there may be conceptual similarities shared between the dynamics of the protofilaments they form.  
Vps24 and Vps2 promote ESCRT‐III helix formation Whereas ESCRT‐II and Vps20 initiate ESCRT‐III assembly that may promote capture cargo, we propose  that Vps24 and Vps2 are  recruited after cargo sequestration  to transform ESCRT‐III into a membrane deforming helix. They achieve this by directly modulating  the  three  dimensional  architecture  of  Snf7  filaments.  By  itself,  Snf7 assembles into spirals that are ostensibly incapable of membrane deformation. The helices generated by  the  co‐assembly of  Snf7, Vps24,  and Vps2 are architecturally distinct  from  these  spirals  and  closely  resemble  protein  helices  formed  by  the membrane  sculpting  protein  dynamin  (Carr  and  Hinshaw  1997).  One  intriguing hypothesis is that the Snf7‐dependent recruitment of Vps24 and Vps2 to endosomes 
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causes Snf7 spirals to reorganize into helices, thus driving membrane invaginations by  a  “molecular  spring”‐like  mechanism.  Protofilament  remodeling  may  generate mechanical force that ultimately leads to membrane bending and the formation of a vesicle  that  buds  into  the  endosomal  interior  (Figure  7C&D).  The  fact  that  Vps24 and  Vps2  can  remodel  pre‐existing  Snf7  protofilaments  into  helices  supports  this model (Figure S5H). This  is further supported by GUV‐based experiments showing that Vps24 and Vps2 promote  the  association of  fluorescent  Snf7 with membrane invaginations  (Figure  S6D‐H).  This model  also  agrees  with  the  proposed  ordered assembly of ESCRT‐III (Teis, Saksena et al. 2008).  Recent  studies  observed  ~17nm  diameter  ESCRT‐III‐dependent  helical  filaments along  the  plasma  membrane  of  cells  undergoing  cytokinetic  abscission  (Guizetti, Schermelleh et al. 2011). Human Snf7 and Vps2 localized along these filaments and were necessary  for  their assembly. One  intriguing hypothesis  is  that  the ESCRT‐III helices  presented  here  represent  structural  analogues  of  the  filaments  that purportedly  drive  mammalian  cytokinetic  abscission,  suggesting  structural conservation in ESCRT function between different biological processes.   Although  we  observed  that  Vps24  and  Vps2  promoted  the  formation  of  protein helices, we  did  not  detect  Vps24/Vps2  “domes”  in  our  assembly  reactions, which have been previously implicated as mediators of ILV formation (Lata, Roessle et al. 2008).  In  these  studies,  “domes”  formed  in  the  absence  of  Snf7  and  only  through significant truncation of Vps24 and Vps2. The experiments presented here indicate 
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that  Snf7,  Vps24,  and  Vps2  may  co‐assemble  into  a  hetero‐oligomeric  helix  to achieve ILV budding.  
The  architecture  of  ESCRT‐III  is  similar  to  other  membrane  sculpting 
oligomers The ESCRT‐III structures observed in this study are conceptually reminiscent of the membrane  scission machines  FtsZ  and  dynamin.  Both  these  proteins  oligomerize during membrane remodeling, as well as interact with other proteins that modulate their  architectural  dynamics.  Intriguingly,  FtsZ  interacts  with  FzlA,  a  protein recently shown to transform linear FtsZ protofilaments into spiraling helices in vitro (Goley, Dye et al. 2011).  Similarly, dynamin  forms helices  that work cooperatively with BAR and F‐BAR proteins to mediate clathrin vesicle release.  One  obvious  difference  between  FtsZ,  dynamin,  and  ESCRT‐III  is  that  FtsZ  and dynamin directly  hydrolyze GTP. This  induces  architectural  changes  that  promote membrane  scission.  Although  ESCRT‐III  subunits  do  not  hydrolyze  NTPs  directly, they  recruit  the  AAA  ATPase  Vps4  that  provides  energy  via  ATP  hydrolysis.  This energy may either be “stored” by ESCRT‐III subunits in their “closed” conformations, or added directly to ESCRT‐III through physical contact with ESCRT‐III helices. Thus, the ~85nm  diameter  ESCRT‐III  helices  presented  here may  represent  a  “relaxed” state that could be constricted or even broken by Vps4.   
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 A  working model:  ESCRT‐III  adopts multiple  architectures  to  achieve  cargo 
sorting  The  existence  of  distinct  architectural  forms  to  ESCRT‐III  suggests  it  matures through at least two stages during its ordered assembly: 1) “early” stage assembly that creates a cargo‐sequestering ring of defined size, and 2) “late”  stage  assembly  that  generates  a  membrane‐sculpting  helix  for  ILV formation.   Several  in  vivo  observations  support  the  existence  of  distinct  stages  to  ESCRT‐III assembly.  Vps24  and  Vps2  constitute  a  sub‐complex  and  are  recruited  during  or after Snf7 polymerization, consistent with their role as “late” modulators of ESCRT‐III architecture. Furthermore, deletion of either Vps24 or Vps2 blocks ILV formation, but  not  cargo  sequestration  at  endosomes  (Teis,  Saksena  et  al.  2010).  Consistent with this are studies showing that blockage of late stages of the ESCRT pathway lead to  receptor  enrichment  at  late  endosomes  and  sustained  EGF  signaling  (Babst, Odorizzi  et  al.  2000).  These  phenomena  could  be  explained  by  the  formation  of ESCRT‐II:ESCRT‐III rings which sequester cargo, but fail execute vesicle formation.  Despite  direct  visualization  of  ESCRT‐III  oligomers,  several  key  questions  remain. The most pressing is the mechanism by which ESCRT‐III mediates vesicle scission. The  structures observed  in  this  study  indicate  several  possible mechanisms. Vps4 could  engage  the  ESCRT‐III  helix  and  drive  filament  sliding  or  constriction.  This 
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Table 4 Expression conditions for reconstituted ESCRT-II and –III complexes 
used in Chapter V 
 
protein E.coli  [IPTG] expression conditions 
His6-Vps20 C41(DE3) 0.4mM overnight (16-20 hours) at 20°C 
His6-Snf7 FL & 
mutants 
BL21 1mM 4 hours at 37°C 
His6-Vps24 C41(DE3) 1mM overnight at 25°C 
His6-Vps2 BL21 1mM overnight at 25°C 
His6-ESCRT-II C41(DE3) 0.3mM 15 hours at 16°C 
GST-Vps25 & 
GST-Vps20core 





Table 5 The following Table summarizes plasmids used in Chapter V for in vitro 
reconstitution of ESCRTs-II and –III: 
 
Supplemental Table 4: Plasmids for Bacterial Expression of ESCRTs-II & -
III 
vector name description reference/source 
pET23d Snf7 (wildtype) full length (fl), N-His6 (Teis, Saksena et 
al. 2008) 
pET23d Snf7R52E full length, R52E, N-His6 this study 
pET23d Snf7L67E full length, L67E, N-His6 this study 
pET23d Snf7K-linker Snf7 160-KAAKKAK-166 this study 
pET23d Snf7core Snf7 1-150, N-His6 this study 
pET23d Snf7A51C full length, A51C, N-His6 this study 
pET23d Snf7T179C full length, T179C, N-His6 this study 
pET23d Snf7redox fl, A51C+T179C, N-His6 this study 
pET23d Snf7R52E+redox fl, A51C+R52E+T179C this study 
pET23d Snf7L67E+redox fl, A51C+L67E+T179C this study 
pET23d Snf7Δlinker fl, Snf7 Δ151-170 this study 
pET23d Snf7R52E+Δhelix5 fl, Snf7R52E + Δ170-183 this study 
pET23d Snf7R52E+V187C fl, R52E+V187C, N- His6 this study 
pOP185 ESCRT-II Vps22, His6-Vps36, 
Vps25 
(Teo, Perisic et al. 
2004) 
pGEX6P1 GST-Vps25 full length Vps25, N-GST this study 
pET23d Vps20 full length, N-His6 this study 
pGEX6P1 GST-Vps20core Vps20 1-147, N-GST this study 
pET23d Vps24 full length, N-His6 this study 





Table 6 Protein samples used in TEM Experiments in Chapter V 
 
Proteins (Panel) [negative stain: UA or AM] Concentrations (µM) 
Figure 3 
Snf7 wildtype (Panel A) [UA] 25 
Snf7R52E (Panels B-J) [B-F:UA, G-J:AM]  25 
Figure 4 
Snf7R52E (Panel A) [UA] 15 
Snf7core (Panel B) [UA] 25 
Snf7R52E+Δhelix5 (Panel D) [UA] 15 
Snf7Δlinker (Panel E) [UA] 15 
Snf7K-linker (Panel F) [UA] 15 
Figure 5 
Snf7R52E on monolayer (ML) (Panel C) [AM] 6 
Snf7R52E (Panel D) [AM] 34.5 
Snf7R52E:Vps24:Vps2 (Panels E&F) [AM] 17, 7, 7 
Snf7R52E:Vps24:Vps2 on ML (Panels G,H, I) [AM] 6, 2.5, 2.5 
Figure 6 
Snf7R52E (Panel B) [AM] 25 
ESCRT-II:Vps20:Snf7R52E (Panels C&E) [AM] 1.8, 4, 25 
ESCRT-II (Panel D) [AM] 4 
Supplemental Figure 3 
Snf7R52E (Panel A) [UA] 34.5 
Snf7R52E (Panel B) [UA] 5, 12.5, 34.5 
Snf7core:Snf7R52E mix (Panel E) [UA] 15,15 
Supplemental Figure 5 
Snf7R52E on lipid monolayers (Panel B) [AM] 6 
Snf7R52E:Vps24 (Panel D) [UA] 11.25, 9 
Snf7R52E:Vps2 (Panel E) [UA] 11.25, 8 
Vps24:Vps2 (Panel F) [UA] 13.5, 12 
Snf7R52E:Vps24: Vps2 (Panel H) [AM] 17, 7, 7 
Supplemental Figure 7 
ESCRT-II:Vps20:Snf7R52E (Panel A) [UA] 1.8, 4, 25 
ESCRT-II:Snf7R52E (Panel B) [UA] 1.8, 25 
Vps20:Snf7R52E (Panel C) [UA] 4, 25 
ESCRT-II:Vps20:Snf7R52E (Panel D) [UA] 0.5, 1, 6 
ESCRT-II:Vps20:Snf7R52E:Vps24:Vps2 (Panel E) 
[UA] 







Table 7 The following Table summarizes yeast strains and pRS plasmids used in 
Chapter V 
 
S. cerevisiae strains 
strain name genotype reference/source 
SEY6210 wild type Matα, leu1-3, 112 ura3-
52 his3-Δ200, trp1-Δ901 
lys2-801 suc2-D9 
(Robinson, Klionsky 
et al. 1988) 
MBY25 vps20Δ 6210; VPS20::HIS3 (Babst, Katzmann et 
al. 2002) 
MBY24 snf7Δ 6210; SNF7::HIS3 (Babst, Katzmann et 
al. 2002) 
BWY102 vps24Δ 6210; VPS24::HIS3 (Babst, Wendland et 
al. 1998) 
MBY28 vps2Δ 6210; VPS2::HIS3 (Babst, Katzmann et 
al. 2002) 
DTY36 vps20Δ, SNF7-GFP 6210.1; VPS20::HIS3 
SNF7-GFP::HIS3MX6 
(Teis, Saksena et al. 
2008) 
DTY25 snf7Δ, VPS24-GFP 6210; SNF7::HIS3 
VPS24-GFP::HIS3MX6 
(Teis, Saksena et al. 
2008) 
DTY235 VPS2-GFP 6210; VPS2-
GFP::HIS3MX6 
(Teis, Saksena et al. 
2008) 
DTY229 vps24Δ, VPS2-GFP 6210.1; VPS24::HIS3 
VPS2-GFP::HIS3MX6 
(Teis, Saksena et al. 
2008) 
DTY11 SNF7-3xFLAG 6210.1; SNF7-
Flag::HIS3MX6 







NBY39 MUP1-pHluorin 6210; MUP1-
pHluorin::KAN 
this study 
S. cerevisiae expression and integration plasmids 
vector name description reference/ 
source 
pRS415 Vps20-GFP full length, C-term GFP this study 
pRS415 Vps20core-GFP Snf7 1-147, C-term GFP this study 
pRS416 Snf7-GFP full length, C-term GFP this study 
pRS416 Snf7 core-GFP Snf7 1-150, C-term GFP this study 
pRS414 Vps24-GFP full length, C-term GFP this study 
pRS414 Vps24core-GFP Snf7 1-142, C-term GFP this study 
pRS415 Vps2core-GFP Snf7 1-143, C-term GFP this study 
pRS416 Snf7 wildtype full length this study 
pRS416 Snf7R52E R52E  this study 
pRS416 Snf7L67E L67E this study 













Snf7 Δ185-195 this study 
pRS416 Snf7core Snf7 1-150 this study 
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